1. Home
  2. STOK vs PMT Comparison

STOK vs PMT Comparison

Compare STOK & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • PMT
  • Stock Information
  • Founded
  • STOK 2014
  • PMT 2009
  • Country
  • STOK United States
  • PMT United States
  • Employees
  • STOK N/A
  • PMT N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • PMT Real Estate Investment Trusts
  • Sector
  • STOK Health Care
  • PMT Real Estate
  • Exchange
  • STOK Nasdaq
  • PMT Nasdaq
  • Market Cap
  • STOK 997.9M
  • PMT 1.1B
  • IPO Year
  • STOK 2019
  • PMT 2009
  • Fundamental
  • Price
  • STOK $19.76
  • PMT $12.32
  • Analyst Decision
  • STOK Strong Buy
  • PMT Hold
  • Analyst Count
  • STOK 6
  • PMT 6
  • Target Price
  • STOK $26.60
  • PMT $14.20
  • AVG Volume (30 Days)
  • STOK 920.7K
  • PMT 624.4K
  • Earning Date
  • STOK 08-12-2025
  • PMT 10-21-2025
  • Dividend Yield
  • STOK N/A
  • PMT 13.00%
  • EPS Growth
  • STOK N/A
  • PMT N/A
  • EPS
  • STOK 0.91
  • PMT 0.72
  • Revenue
  • STOK $199,893,000.00
  • PMT $614,826,000.00
  • Revenue This Year
  • STOK $415.58
  • PMT N/A
  • Revenue Next Year
  • STOK N/A
  • PMT $28.12
  • P/E Ratio
  • STOK $21.55
  • PMT $17.11
  • Revenue Growth
  • STOK 1218.82
  • PMT 13.07
  • 52 Week Low
  • STOK $5.35
  • PMT $11.70
  • 52 Week High
  • STOK $20.00
  • PMT $14.93
  • Technical
  • Relative Strength Index (RSI)
  • STOK 78.62
  • PMT 52.34
  • Support Level
  • STOK $19.07
  • PMT $12.05
  • Resistance Level
  • STOK $19.91
  • PMT $12.36
  • Average True Range (ATR)
  • STOK 1.26
  • PMT 0.20
  • MACD
  • STOK 0.14
  • PMT 0.04
  • Stochastic Oscillator
  • STOK 96.55
  • PMT 85.29

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About PMT PennyMac Mortgage Investment Trust of Beneficial Interest

PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.

Share on Social Networks: